Prevention of influenza and pneumococcal pneumonia in Canadian long-term care facilities: How are we doing?

CMAJ. Canadian Medical Association Journal

Volumn 164, Issue 10, 2001, Pages 1413-1419

  Stevenson, C G ^a   McArthur, M A ^a   Naus, M ^a   Abraham, E ^a   McGeer, A J ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

AGED; ARTICLE; DRUG EFFICACY; HEALTH CARE FACILITY; HOSPITAL ADMISSION; HUMAN; INFECTION CONTROL; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A; LOBAR PNEUMONIA; QUESTIONNAIRE; SIDE EFFECT;

EID: 0034902303     PISSN: 08203946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Influenza and pneumococcal vaccination in Canada and the United States, 1980-1993: What can the two countries learn from each other?
2. Canadian consensus conference on influenza
3. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
4. Should staff in long-stay hospitals for elderly patients be vaccinated against influenza?
5. Immunizations in long-term care facilities: Policies and practice
6. Pneumococcal vaccines: World Health Organization position paper
7. Assessing the potential impact of vaccination programs on invasive pneumococcal disease: Data from population-based surveillance
8. Statement on influenza vaccination for the 2000-2001 season
9. Influenza vaccine, 1999-2000
10. Pneumococcal vaccine
11. Protecting against invasive pneumococcal disease: Be wise -Immunize!
12. Influenza vaccination in long-term care facilities: Structuring programs for success
13. Influenza and pneumococcal vaccination and tuberculin skin testing programs in long-term care facilities: Where do we stand?
14. Effectiveness of influenza vaccine in health care professionals: A randomized trial
15. The effectiveness of vaccination against influenza in healthy, working adults
16. Effectiveness of live, attenuated intranasal influenza vaccine in healthy, working adults: A randomized controlled trial
17. A worksite influenza immunization program: Impact on lost work days, health care utilization, and health care spending
18. Effectiveness and cost-benefit of an influenza vaccination program for health care workers
19. Effects of influenza vaccination of health-care workers on mortality of elderly people in long-term care: A randomised controlled trial
20. Influenza vaccination of health care workers in long-term-care hospitals reduces the mortality of elderly patients
21. Pneumococcal vaccination in the United States and 20 other developed countries, 1981-1996
22. Influenza and pneumococcal vaccination levels among adults aged greater than or equal to 65 years - United States
23. Essai clinique du vaccin antipneumococcique chez personnes âgées vivant en institution
24. Clinical efficacy of pneumococcal vaccine in the elderly: A randomized, single-blind population-based trial
25. Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people
26. Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study
27. Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia among persons aged 65 years or older
28. Preventing pneumococcal bacteremia in patients at risk
29. Cost effectiveness of vaccination against pneumococcal bacteremia among elderly people
30. Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials
31. Effectiveness of a pneumococcal vaccination program in preventing invasive pneumococcal disease
32. Amantadine and rimantadine for preventing and treating influenza A in adults
33. The roles of vaccination and amantadine prophylaxis in controlling an outbreak of influenza A (H3N2) in a nursing home
34. Control of influenza A outbreaks in nursing homes: Amantadine as an adjunct to vaccine - Washington, 1989-90
35. Influenza A outbreak in a nursing home: The value of early diagnosis and the use of amantadine hydrochloride
36. Sequential outbreak of influenza A and B in a nursing home: Efficacy of vaccine and amantadine
37. Influenza control in long-term care facilities: The Perth County experience
38. Antivirals for pandemic influenza
39. Control of influenza outbreaks in the nursing home: Guidelines for diagnosis and management
40. Occurrence of adverse effects and high amantadine concentrations with influenza prophylaxis in the nursing home
41. Treatment of an influenza A outbreak in a teaching nursing home. Effectiveness of a protocol for prevention and control
42. Adverse reactions to amantadine prophylaxis of influenza in a retirement home
43. Amantadine use in influenza outbreaks in long-term care facilities
44. Influenza virus neuraminidase inhibitors